… is a drug effect (option A), specifically pupillary dilatation and the possible risk of acute
angle glaucoma secondary to topical deposition on the eye of nebulized bronchodilators. …

… As was evidenced by our review of the literature, low risk pa… high economic costs or elevated
risk of iatrogenic illness possibly … dose of albuterol administered with the nebulizer was not …

… and JN (‘nebulizer’) were equivalent using measures such as bronchodilation [Citation4], but
… de-recruitment, and mitigates against the risk of release of infectious and medical aerosols. …

… with FEV 1 < 80%, prior asthma medication use such as short-acting bronchodilators and
long-acting beta 2 -agonists SCS prescribed asthma patients had increased cataract risk …

… and physiologic saline, but not between albuterol and physiologic saline. Intramuscular …
Nebulized racemic epinephrine and albuterol are safe and useful in the treatment of acute …

… , in comparison with patients using albuterol alone. Similar findings … between 6 months and
8 years of age using nebulized … As part of the Blue Mountains Eye study, risk of cataract was …

… ocular reactions, to appreciate their significance, and to inform the patient of the potential
risks of … Acute angle closure glaucoma occurring after nebulized bronchodilator treatment with …

… risk for score±improved was 0.76 (95% CI, 0.60 to 0.95; P=.02), favoring treatment.
Bronchodilators had no effect on hospitalization (relative risk… trials in which only nebulized …

… and MDI quick-relief medication was predominantly albuterol (baseline, 95%; … risks
associated with nebulizer use, such as adequate storage of the device. Contamination of nebulizer …

… this risk virtually to nil, provided that one takes care that the drug is not nebulized into the
eye … In this study, elderly patients had a greater risk of life-threatening events than younger …